February 11, 2021

Journal Club Presents: Systemic Treatment Effects on Comorbidities of Psoriasis

Episode 114

A discussion with dermatologist Dr. Mark Lebwohl, cardiologist Dr. Nehal Mehta and Dr. Heather Teague, Post-Doctoral Fellow, NIH Inflammation and Cardiometabolic Disease Laboratory.

Hear dermatologist Dr. Mark Lebwohl, Mt Sinai Health System, cardiologist and Chief of the Section of Inflammation and Cardiometabolic Diseases at the National Institutes of Health in Bethesda, Dr. Nehal Mehta, and Dr. Heather Teague, also from the NIH Section of Inflammation & Cardiometabolic Diseases discuss the effect of systemic psoriasis treatments on CVD, diabetes, and psoriatic arthritis.

This program is supported by educational grants from AbbVie, Amgen, Janssen and UCB.

Related Items

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorCommunity Health Charities logo

Copyright © 1996-2024 National Psoriasis Foundation/USA

Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).

NPF does not endorse or accept any responsibility for the content of external websites.

NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.